|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.09 USD | +3.54% |
|
+3.02% | -14.79% |
| Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
Novavax, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 983.71 million compared to USD 1,981.87 million a year ago. Net loss was USD 545.06 million compared to USD 657.94 million a year ago.
Basic loss per share from continuing operations was USD 5.41 compared to USD 8.42 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.79% | 572M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
NOVAVAX, INC. 
